Submit Release
Contact Us Journalists Sign Up Login
Submit Release
Login

Email This News Release

"First Heart Attack Patient Treated in European Cardioprotection Phase III Trial with NeuroVive's CicloMulsion (TM)"

Your privacy is important to us. We will never share your email or other information with a third party.

Logo

24-7 Press Release Service

Telephone Hours
Monday to Friday
8:30am to 5:00pm PST
Toll Free
1-888-880-9539 Telephone
646-417-8294
US Address:
Smith Tower
Suite 1400 - 506 Second Avenue
Seattle, WA
98104, USA
Address:
Suite 203 - 901 West 3rd St.
North Vancouver, BC
V7P 3P9, Canada